Shuttle Pharmaceuticals (SHPH) Competitors $3.59 +0.11 (+3.16%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$3.49 -0.10 (-2.79%) As of 09/12/2025 05:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SHPH vs. CYCC, COCP, ETHZ, ATNF, CMMB, IMNN, PHIO, ABP, NXTC, and BIVIShould you be buying Shuttle Pharmaceuticals stock or one of its competitors? The main competitors of Shuttle Pharmaceuticals include Cyclacel Pharmaceuticals (CYCC), Cocrystal Pharma (COCP), Flag Ship Acquisition (ETHZ), 180 Life Sciences (ATNF), Chemomab Therapeutics (CMMB), Imunon (IMNN), Phio Pharmaceuticals (PHIO), Abpro (ABP), NextCure (NXTC), and BioVie (BIVI). These companies are all part of the "pharmaceutical products" industry. Shuttle Pharmaceuticals vs. Its Competitors Cyclacel Pharmaceuticals Cocrystal Pharma Flag Ship Acquisition 180 Life Sciences Chemomab Therapeutics Imunon Phio Pharmaceuticals Abpro NextCure BioVie Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership, media sentiment and dividends. Which has more risk & volatility, CYCC or SHPH? Cyclacel Pharmaceuticals has a beta of 0.15, indicating that its share price is 85% less volatile than the S&P 500. Comparatively, Shuttle Pharmaceuticals has a beta of -1.08, indicating that its share price is 208% less volatile than the S&P 500. Is CYCC or SHPH more profitable? Cyclacel Pharmaceuticals' return on equity of -723.64% beat Shuttle Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Cyclacel PharmaceuticalsN/A -723.64% -145.51% Shuttle Pharmaceuticals N/A -772.76%-347.06% Does the media favor CYCC or SHPH? In the previous week, Cyclacel Pharmaceuticals and Cyclacel Pharmaceuticals both had 3 articles in the media. Shuttle Pharmaceuticals' average media sentiment score of 0.97 beat Cyclacel Pharmaceuticals' score of 0.30 indicating that Shuttle Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cyclacel Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Shuttle Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend CYCC or SHPH? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cyclacel Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Shuttle Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has preferable valuation and earnings, CYCC or SHPH? Shuttle Pharmaceuticals has lower revenue, but higher earnings than Cyclacel Pharmaceuticals. Shuttle Pharmaceuticals is trading at a lower price-to-earnings ratio than Cyclacel Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCyclacel Pharmaceuticals$40K360.64-$11.21M-$839.58-0.01Shuttle PharmaceuticalsN/AN/A-$9.15M-$4.15-0.87 Do institutionals & insiders hold more shares of CYCC or SHPH? 23.6% of Cyclacel Pharmaceuticals shares are held by institutional investors. Comparatively, 4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. 51.2% of Cyclacel Pharmaceuticals shares are held by company insiders. Comparatively, 12.6% of Shuttle Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryCyclacel Pharmaceuticals beats Shuttle Pharmaceuticals on 8 of the 11 factors compared between the two stocks. Get Shuttle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SHPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SHPH vs. The Competition Export to ExcelMetricShuttle PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.84M$2.56B$5.79B$10.19BDividend YieldN/A57.24%5.73%4.60%P/E Ratio-0.875.3956.5722.28Price / SalesN/A678.28529.93120.07Price / CashN/A27.5625.8129.91Price / Book0.835.3812.166.25Net Income-$9.15M$32.95M$3.29B$270.76M7 Day Performance6.37%1.28%0.74%3.87%1 Month Performance2.57%5.61%5.00%5.49%1 Year Performance-91.55%-1.67%62.55%25.86% Shuttle Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SHPHShuttle Pharmaceuticals1.1359 of 5 stars$3.59+3.2%N/A-91.6%$3.84MN/A-0.875Short Interest ↓Gap DownHigh Trading VolumeCYCCCyclacel Pharmaceuticals0.418 of 5 stars$6.66-5.5%N/A-97.4%$14.91M$10K-0.0114Short Interest ↑COCPCocrystal Pharma2.2588 of 5 stars$1.45-3.3%$6.00+313.8%-6.0%$14.88MN/A-1.1710News CoverageShort Interest ↑Gap UpETHZFlag Ship AcquisitionN/A$2.44flatN/AN/A$14.74MN/A-0.167High Trading VolumeATNF180 Life Sciences0.189 of 5 stars$2.44+5.6%N/A+36.4%$14.74MN/A-0.167CMMBChemomab Therapeutics2.6265 of 5 stars$3.05flat$26.50+768.9%-57.4%$14.37MN/A-1.2920News CoverageShort Interest ↑IMNNImunon2.3922 of 5 stars$5.82flat$232.50+3,894.8%-63.1%$14.20M$500K-0.4530Short Interest ↓PHIOPhio Pharmaceuticals3.0126 of 5 stars$2.44+15.1%$14.00+473.8%-33.9%$13.98MN/A-0.7510Positive NewsAnalyst UpgradeShort Interest ↓Gap DownABPAbpro3.9504 of 5 stars$0.17-21.5%$4.00+2,241.9%N/A$13.69M$183K0.0015Positive NewsNXTCNextCure4.7469 of 5 stars$5.07+3.0%$25.50+403.0%-68.5%$13.59MN/A-0.2090Positive NewsShort Interest ↓Gap DownBIVIBioVie0.6683 of 5 stars$1.79-0.6%N/A-94.1%$13.48MN/A-0.0210Positive NewsGap UpHigh Trading Volume Related Companies and Tools Related Companies CYCC Alternatives COCP Alternatives ETHZ Alternatives ATNF Alternatives CMMB Alternatives IMNN Alternatives PHIO Alternatives ABP Alternatives NXTC Alternatives BIVI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SHPH) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s right about Epstein.A crisis that could devastate your wealth, upend the dollar, and accelerate the collapse of America’s economy....Porter & Company | SponsoredThe Obscure Korean War Act That Created a $5.39 Billion Passive Income StreamAn obscure Korean War law has just been enacted by the U.S. government... Allowing it to take a heavy hand ...Angel Publishing | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shuttle Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shuttle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SHPH Stock Alerts